Intelligence Platform
Patents
Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12201655
Antimicrobial therapy
granted patentUS 12201658
Viral gene therapy as treatment for cholesterol storage disease or disorder
granted patentUS 12201719
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
granted patentUS 12194016
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted patentUS 12194061
Processes for production of tumor infiltrating lymphocytes and uses of same in immunothera
granted patentUS 12186428
Combination taxoid nanoemulsion with immunotherapy in cancer
granted patentUS 12186369
Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, i
granted patentUS 12178787
T cell receptors for immunotherapy
granted patentUS 12173314
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected au
granted patentUS 12170134
Systems and methods for coordinating manufacturing of cells for patient-specific immunothe
granted patentUS 12161733
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging ag
granted patentUS 12156863
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
granted patentUS 12159700
Systems and methods for coordinating manufacturing of cells for patient-specific immunothe
granted patentUS 12156879
Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy
granted patentUS 12151001
Optimized expression cassettes for gene therapy
granted patentUS 12152242
CRISPR therapy
granted patentUS 12121541
Processes for production of tumor infiltrating lymphocytes and uses of same in immunothera
granted patentUS 12121580
Antibacterial photodynamic therapy using copper-cysteamine nanoparticles
granted patentUS 12121540
CBL inhibitors and compositions for use in adoptive cell therapy
granted patentUS 12115163
Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor
granted patentUS 12110334
Neutralizing antibodies to the Ξ±vΞ²8 integrin complex for immunotherapy
granted patentUS 12110504
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected au
granted patentUS 12097213
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation thera
granted patentUS 12098385
Gene therapy strategy to restore cardiac electrical and structural function in arrhythmoge
granted